MER N5075A
Latest Information Update: 07 Jun 2001
At a glance
- Originator Mercian
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 07 Jun 2001 Discontinued-Preclinical for HIV infections treatment in Japan (Unknown route)